KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Minority Interest (2016 - 2026)

Zimmer Biomet Holdings has reported Minority Interest over the past 16 years, most recently at $8.2 million for Q1 2026.

  • For Q1 2026, Minority Interest fell 5.75% year-over-year to $8.2 million; the TTM value through Mar 2026 reached $8.2 million, down 5.75%, while the annual FY2025 figure was $8.1 million, 0.0% changed from the prior year.
  • Minority Interest for Q1 2026 was $8.2 million at Zimmer Biomet Holdings, up from $8.1 million in the prior quarter.
  • Over five years, Minority Interest peaked at $9.5 million in Q3 2025 and troughed at $5.9 million in Q1 2022.
  • A 5-year average of $7.7 million and a median of $8.1 million in 2024 define the central range for Minority Interest.
  • Biggest five-year swings in Minority Interest: grew 22.92% in 2022 and later fell 5.75% in 2026.
  • Year by year, Minority Interest stood at $6.7 million in 2022, then grew by 14.93% to $7.7 million in 2023, then rose by 5.19% to $8.1 million in 2024, then changed by 0.0% to $8.1 million in 2025, then grew by 1.23% to $8.2 million in 2026.
  • Business Quant data shows Minority Interest for ZBH at $8.2 million in Q1 2026, $8.1 million in Q4 2025, and $9.5 million in Q3 2025.